These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 7479174

  • 1. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG, Stanton MS, Benditt DG, Trusty J, Collins J.
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ.
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.
    Neglia JJ, Krol RB, Giorgberidze I, Mathew P, Lewis C, Munsif AN, Saksena S.
    J Interv Card Electrophysiol; 1997 Feb; 1(1):49-56. PubMed ID: 9869951
    [Abstract] [Full Text] [Related]

  • 4. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 5. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL, Hess M, Young J, Abraham WT.
    J Cardiovasc Electrophysiol; 2004 Sep 12; 15(9):1002-9. PubMed ID: 15363071
    [Abstract] [Full Text] [Related]

  • 6. Implantable transvenous cardioverter-defibrillators.
    Bardy GH, Hofer B, Johnson G, Kudenchuk PJ, Poole JE, Dolack GL, Gleva M, Mitchell R, Kelso D.
    Circulation; 1993 Apr 12; 87(4):1152-68. PubMed ID: 8462144
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.
    Grimm W, Flores BF, Marchlinski FE.
    Pacing Clin Electrophysiol; 1992 Nov 12; 15(11 Pt 1):1667-73. PubMed ID: 1279533
    [Abstract] [Full Text] [Related]

  • 8. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł, Kornacewicz-Jach Z, Kaźmierczak J, Rzeuski R, Zielonka J, Kaliszczak R, Safranow K.
    Cardiol J; 2009 Nov 12; 16(5):432-9. PubMed ID: 19753522
    [Abstract] [Full Text] [Related]

  • 9. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ.
    J Cardiovasc Electrophysiol; 2017 May 12; 28(5):531-537. PubMed ID: 28240435
    [Abstract] [Full Text] [Related]

  • 10. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias.
    Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ.
    Am J Cardiol; 1992 Oct 15; 70(11):1017-22. PubMed ID: 1414898
    [Abstract] [Full Text] [Related]

  • 11. Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices.
    Oesterle A, Dhruva SS, Pellegrini CN, Liem B, Raitt MH.
    J Interv Card Electrophysiol; 2023 Oct 15; 66(7):1679-1691. PubMed ID: 36737506
    [Abstract] [Full Text] [Related]

  • 12. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 15; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 13. Dual chamber implantable cardioverter defibrillator benefits and limitations.
    Fan K, Lee K, Lau CP.
    J Interv Card Electrophysiol; 1999 Oct 15; 3(3):239-45. PubMed ID: 10490480
    [Abstract] [Full Text] [Related]

  • 14. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 15. Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.
    Singer I, Adams L, Austin E.
    Pacing Clin Electrophysiol; 1993 May 08; 16(5 Pt 1):1070-9. PubMed ID: 7685888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J, Schneider MA, Kuck KH.
    Z Kardiol; 1993 Nov 08; 82(11):683-91. PubMed ID: 8291289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, Chen PS.
    Circulation; 1997 Mar 18; 95(6):1497-504. PubMed ID: 9118518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.